ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peripheral Parenteral Nutrition (PPN) Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-25J10583
Home | Market Reports | Health| Nursing
Global Peripheral Parenteral Nutrition PPN Market Research Report 2022
BUY CHAPTERS

Global Peripheral Parenteral Nutrition (PPN) Market Research Report 2025

Code: QYRE-Auto-25J10583
Report
March 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical

Peripheral Parenteral Nutrition (PPN) Market

The global market for Peripheral Parenteral Nutrition (PPN) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Peripheral Parenteral Nutrition (PPN) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peripheral Parenteral Nutrition (PPN) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Peripheral Parenteral Nutrition (PPN) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Peripheral Parenteral Nutrition (PPN) include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peripheral Parenteral Nutrition (PPN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Parenteral Nutrition (PPN).
The Peripheral Parenteral Nutrition (PPN) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peripheral Parenteral Nutrition (PPN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Parenteral Nutrition (PPN) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peripheral Parenteral Nutrition (PPN) Market Report

Report Metric Details
Report Name Peripheral Parenteral Nutrition (PPN) Market
Segment by Type
Segment by Application
  • Hospital
  • Home
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, Laboratorios Finlay, Grifols International, Fresenius Kabi, Sichuan Kelun Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peripheral Parenteral Nutrition (PPN) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peripheral Parenteral Nutrition (PPN) Market report?

Ans: The main players in the Peripheral Parenteral Nutrition (PPN) Market are Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, Laboratorios Finlay, Grifols International, Fresenius Kabi, Sichuan Kelun Pharmaceutical

What are the Application segmentation covered in the Peripheral Parenteral Nutrition (PPN) Market report?

Ans: The Applications covered in the Peripheral Parenteral Nutrition (PPN) Market report are Hospital, Home

What are the Type segmentation covered in the Peripheral Parenteral Nutrition (PPN) Market report?

Ans: The Types covered in the Peripheral Parenteral Nutrition (PPN) Market report are Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals

Recommended Reports

Parenteral Nutrition

Peripheral Vascular

Clinical Nutrition

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Carbohydrates
1.2.3 Parenteral Lipid Emulsion
1.2.4 Single Dose Amino Acid Solution
1.2.5 Trace Elements
1.2.6 Vitamins and Minerals
1.3 Market by Application
1.3.1 Global Peripheral Parenteral Nutrition (PPN) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Home
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Parenteral Nutrition (PPN) Market Perspective (2020-2031)
2.2 Global Peripheral Parenteral Nutrition (PPN) Growth Trends by Region
2.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peripheral Parenteral Nutrition (PPN) Historic Market Size by Region (2020-2025)
2.2.3 Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2026-2031)
2.3 Peripheral Parenteral Nutrition (PPN) Market Dynamics
2.3.1 Peripheral Parenteral Nutrition (PPN) Industry Trends
2.3.2 Peripheral Parenteral Nutrition (PPN) Market Drivers
2.3.3 Peripheral Parenteral Nutrition (PPN) Market Challenges
2.3.4 Peripheral Parenteral Nutrition (PPN) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue
3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue (2020-2025)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Players (2020-2025)
3.2 Global Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peripheral Parenteral Nutrition (PPN) Revenue
3.4 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio
3.4.1 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) Revenue in 2024
3.5 Global Key Players of Peripheral Parenteral Nutrition (PPN) Head office and Area Served
3.6 Global Key Players of Peripheral Parenteral Nutrition (PPN), Product and Application
3.7 Global Key Players of Peripheral Parenteral Nutrition (PPN), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Type
4.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Type (2020-2025)
4.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2026-2031)
5 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Application
5.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Application (2020-2025)
5.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
6.2 North America Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
6.4 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
7.4 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2020-2025)
8.4 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
9.2 Latin America Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
9.4 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
10.4 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofarma
11.1.1 Eurofarma Company Details
11.1.2 Eurofarma Business Overview
11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Introduction
11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.1.5 Eurofarma Recent Development
11.2 Corporacion De Laboratorios Farmaceuticos
11.2.1 Corporacion De Laboratorios Farmaceuticos Company Details
11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Introduction
11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Details
11.3.2 Baxter International Inc. Business Overview
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Introduction
11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.3.5 Baxter International Inc. Recent Development
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Details
11.4.2 Kelun Pharma Business Overview
11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Introduction
11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.4.5 Kelun Pharma Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Details
11.5.2 B. Braun Business Overview
11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Introduction
11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.5.5 B. Braun Recent Development
11.6 Fresenius
11.6.1 Fresenius Company Details
11.6.2 Fresenius Business Overview
11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Introduction
11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.6.5 Fresenius Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer (Hospira)
11.8.1 Pfizer (Hospira) Company Details
11.8.2 Pfizer (Hospira) Business Overview
11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Introduction
11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.8.5 Pfizer (Hospira) Recent Development
11.9 Ostuka Pharmaceutical
11.9.1 Ostuka Pharmaceutical Company Details
11.9.2 Ostuka Pharmaceutical Business Overview
11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.9.5 Ostuka Pharmaceutical Recent Development
11.10 Laboratorios Biogalenic
11.10.1 Laboratorios Biogalenic Company Details
11.10.2 Laboratorios Biogalenic Business Overview
11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Introduction
11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.10.5 Laboratorios Biogalenic Recent Development
11.11 Laboratorios Finlay
11.11.1 Laboratorios Finlay Company Details
11.11.2 Laboratorios Finlay Business Overview
11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Introduction
11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.11.5 Laboratorios Finlay Recent Development
11.12 Grifols International
11.12.1 Grifols International Company Details
11.12.2 Grifols International Business Overview
11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Introduction
11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.12.5 Grifols International Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Details
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Introduction
11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.13.5 Fresenius Kabi Recent Development
11.14 Sichuan Kelun Pharmaceutical
11.14.1 Sichuan Kelun Pharmaceutical Company Details
11.14.2 Sichuan Kelun Pharmaceutical Business Overview
11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.14.5 Sichuan Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical
List of Tables
 Table 1. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Carbohydrates
 Table 3. Key Players of Parenteral Lipid Emulsion
 Table 4. Key Players of Single Dose Amino Acid Solution
 Table 5. Key Players of Trace Elements
 Table 6. Key Players of Vitamins and Minerals
 Table 7. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2020-2025)
 Table 11. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2026-2031)
 Table 13. Peripheral Parenteral Nutrition (PPN) Market Trends
 Table 14. Peripheral Parenteral Nutrition (PPN) Market Drivers
 Table 15. Peripheral Parenteral Nutrition (PPN) Market Challenges
 Table 16. Peripheral Parenteral Nutrition (PPN) Market Restraints
 Table 17. Global Peripheral Parenteral Nutrition (PPN) Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players (2020-2025)
 Table 19. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2024)
 Table 20. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Peripheral Parenteral Nutrition (PPN), Headquarters and Area Served
 Table 23. Global Key Players of Peripheral Parenteral Nutrition (PPN), Product and Application
 Table 24. Global Key Players of Peripheral Parenteral Nutrition (PPN), Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Peripheral Parenteral Nutrition (PPN) Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2020-2025)
 Table 28. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2026-2031)
 Table 30. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2020-2025)
 Table 32. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2026-2031)
 Table 34. North America Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Eurofarma Company Details
 Table 50. Eurofarma Business Overview
 Table 51. Eurofarma Peripheral Parenteral Nutrition (PPN) Product
 Table 52. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 53. Eurofarma Recent Development
 Table 54. Corporacion De Laboratorios Farmaceuticos Company Details
 Table 55. Corporacion De Laboratorios Farmaceuticos Business Overview
 Table 56. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product
 Table 57. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 58. Corporacion De Laboratorios Farmaceuticos Recent Development
 Table 59. Baxter International Inc. Company Details
 Table 60. Baxter International Inc. Business Overview
 Table 61. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product
 Table 62. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 63. Baxter International Inc. Recent Development
 Table 64. Kelun Pharma Company Details
 Table 65. Kelun Pharma Business Overview
 Table 66. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product
 Table 67. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 68. Kelun Pharma Recent Development
 Table 69. B. Braun Company Details
 Table 70. B. Braun Business Overview
 Table 71. B. Braun Peripheral Parenteral Nutrition (PPN) Product
 Table 72. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 73. B. Braun Recent Development
 Table 74. Fresenius Company Details
 Table 75. Fresenius Business Overview
 Table 76. Fresenius Peripheral Parenteral Nutrition (PPN) Product
 Table 77. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 78. Fresenius Recent Development
 Table 79. Teva Pharmaceutical Industries Company Details
 Table 80. Teva Pharmaceutical Industries Business Overview
 Table 81. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product
 Table 82. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 83. Teva Pharmaceutical Industries Recent Development
 Table 84. Pfizer (Hospira) Company Details
 Table 85. Pfizer (Hospira) Business Overview
 Table 86. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product
 Table 87. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 88. Pfizer (Hospira) Recent Development
 Table 89. Ostuka Pharmaceutical Company Details
 Table 90. Ostuka Pharmaceutical Business Overview
 Table 91. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
 Table 92. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 93. Ostuka Pharmaceutical Recent Development
 Table 94. Laboratorios Biogalenic Company Details
 Table 95. Laboratorios Biogalenic Business Overview
 Table 96. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product
 Table 97. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 98. Laboratorios Biogalenic Recent Development
 Table 99. Laboratorios Finlay Company Details
 Table 100. Laboratorios Finlay Business Overview
 Table 101. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product
 Table 102. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 103. Laboratorios Finlay Recent Development
 Table 104. Grifols International Company Details
 Table 105. Grifols International Business Overview
 Table 106. Grifols International Peripheral Parenteral Nutrition (PPN) Product
 Table 107. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 108. Grifols International Recent Development
 Table 109. Fresenius Kabi Company Details
 Table 110. Fresenius Kabi Business Overview
 Table 111. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product
 Table 112. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 113. Fresenius Kabi Recent Development
 Table 114. Sichuan Kelun Pharmaceutical Company Details
 Table 115. Sichuan Kelun Pharmaceutical Business Overview
 Table 116. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
 Table 117. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
 Table 118. Sichuan Kelun Pharmaceutical Recent Development
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources
 Table 122. Authors List of This Report


List of Figures
 Figure 1. Peripheral Parenteral Nutrition (PPN) Picture
 Figure 2. Global Peripheral Parenteral Nutrition (PPN) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peripheral Parenteral Nutrition (PPN) Market Share by Type: 2024 VS 2031
 Figure 4. Carbohydrates Features
 Figure 5. Parenteral Lipid Emulsion Features
 Figure 6. Single Dose Amino Acid Solution Features
 Figure 7. Trace Elements Features
 Figure 8. Vitamins and Minerals Features
 Figure 9. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Peripheral Parenteral Nutrition (PPN) Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Home Case Studies
 Figure 13. Peripheral Parenteral Nutrition (PPN) Report Years Considered
 Figure 14. Global Peripheral Parenteral Nutrition (PPN) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Peripheral Parenteral Nutrition (PPN) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region: 2024 VS 2031
 Figure 17. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players in 2024
 Figure 18. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue in 2024
 Figure 20. North America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
 Figure 22. United States Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
 Figure 26. Germany Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Share by Region (2020-2031)
 Figure 34. China Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
 Figure 42. Mexico Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
 Figure 46. Turkey Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 50. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 51. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 52. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 53. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 54. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 56. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 57. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 58. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 59. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 60. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 61. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 62. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Peripheral Parenteral Nutrition PPN and Total Parenteral Nutrition TPN Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Total Parenteral Nutrition TPN Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Parenteral Nutrition Bags Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Parenteral Nutrition Products Market Research Report 2024
Global Parenteral Nutrition Emulsion Market Research Report 2025
Global Parenteral Nutrition Medical Devices and Consumables Market Research Report 2024
Global Peripheral Intervention Products Market Research Report 2024
Peripheral Vascular Guidewire Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global EVA TPN Total Parenteral Nutrition Bags Market Research Report 2024
Global Peripheral Catheters Market Research Report 2025
Global Parenteral Nutrition Medicament Market Research Report 2025
Global Total Parenteral Nutrition TPN Market Research Report 2024
Global Diagnostic Peripheral Catheter Market Research Report 2025
Global PFPN Market Research Report 2024
Global Short Peripheral Intravenous Catheters Market Research Report 2025
Global 3 Chamber Bags for Parenteral Nutrition Market Research Report 2024
Global Total Parenteral Nutrition TPN Bags Market Research Report 2024
Therapeutic Nutrients And Minerals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Parenteral Nutrition Infusion Bag Market Research Report 2024
Global Ammonium Nitrate Porous Prilled PPAN Market Research Report 2025

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions